Modulation of Human Intraocular Pressure Using a Pneumatic System.
Journal
Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919
Informations de publication
Date de publication:
01 12 2021
01 12 2021
Historique:
entrez:
2
12
2021
pubmed:
3
12
2021
medline:
27
1
2022
Statut:
ppublish
Résumé
To technically validate a novel pneumatically based system and method for modulation of intraocular pressure (IOP) and to test its application in the human eye. Special attention was paid to the applicability of the pneumatically driven balloon, which realizes the modulation of the IOP through its contact with the conjunctiva. A force sensor as key component of a customized measurement setup was used to check the applied pressure through the balloon. The IOP of 10 healthy subjects (4 female, 6 male, aged 28.8 ± 6.64 years) was modulated and increased linearly to at least 40 mmHg. At this point, the pressure inside the balloon was kept constant for 2 minutes, with IOP measurements taken every 40 seconds using a rebound tonometer. The technical setup led to an IOP decrease of 0.71 mmHg within 2 minutes at an operating point of 40 mmHg. For all subjects, the IOP could be increased up to 42.8 ± 3.6 mmHg, whereby a mean pressure decrease of 2.4 mmHg/min was determined, which seems to be caused mainly by physiological processes. With the new pneumatically based setup, a targeted modulation in terms of level and constancy of the IOP can be realized. Additional and, compared with the technique according to Löw, a more precise and more constant methodology for the modulation of the IOP, can significantly simplify the determination of retinal vessel pressures for clinical application. It is suitable for practical questions concerning an enhanced retinal venous pressure.
Identifiants
pubmed: 34854893
pii: 2778134
doi: 10.1167/tvst.10.14.4
pmc: PMC8648048
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4Références
Graefes Arch Clin Exp Ophthalmol. 2003 May;241(5):367-70
pubmed: 12698255
Klin Monbl Augenheilkd. 2016 Jul;233(7):847-55
pubmed: 27130978
Ophthalmic Res. 1985;17(5):308-17
pubmed: 4069567
Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1307-12
pubmed: 15790896
Ophthalmologe. 2008 Apr;105(4):376-80
pubmed: 17987294
Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6620-4
pubmed: 20505204
Br J Ophthalmol. 2014 Oct;98(10):1374-8
pubmed: 24820045
Klin Monbl Augenheilkd. 2004 Dec;221(12):1007-11
pubmed: 15599806
Acta Ophthalmol Scand. 2000 Apr;78(2):142-5
pubmed: 10794245
Graefes Arch Clin Exp Ophthalmol. 2004 Jan;242(1):3-7
pubmed: 14634828
BMC Ophthalmol. 2014 Oct 13;14:121
pubmed: 25312339
Prog Retin Eye Res. 2016 Nov;55:82-107
pubmed: 27417037
Acta Ophthalmol. 2013 Aug;91(5):e392-6
pubmed: 23521889
Curr Opin Pharmacol. 2013 Feb;13(1):36-42
pubmed: 23009741
EPMA J. 2015 Feb 24;6(1):5
pubmed: 25793018
PLoS One. 2017 Jan 9;12(1):e0169438
pubmed: 28068365
Br J Ophthalmol. 2003 May;87(5):577-9
pubmed: 12714398
EPMA J. 2015 Oct 26;6:21
pubmed: 26504500
Invest Ophthalmol Vis Sci. 2013 Jul 12;54(7):4698-704
pubmed: 23716629
Arch Ophthalmol. 1962 Apr;67:424-7
pubmed: 14466938
Ophthalmology. 2004 Aug;111(8):1489-94
pubmed: 15288976
Klin Monbl Augenheilkd. 2021 Jan 12;:
pubmed: 33434930
Klin Monbl Augenheilkd. 1987 Feb;190(2):109-13
pubmed: 3573661
Br J Ophthalmol. 2007 Apr;91(4):441-4
pubmed: 17035270